The PERCIVIA PER.C6® Development Center, Cambridge, Massachusetts, specializes in further developing the PER.C6® human cell line as the premier platform for the expression of recombinant pharmaceutical proteins. This center of excellence offers a fully integrated technology platform that is capable of providing turnkey solutions for the production of pharmaceutical proteins to the biotech industry. This comprehensive platform encompasses cell line generation technology, cell culture media development, upstream and downstream processes design, scale-up, technology transfer, and regulatory support. PERCIVIA’s professional staff works in state-of-the-art laboratories with sufficient space to afford PER.C6® customers a hands-on experience of the technology.